DCM
MR

Dialectic Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Dialectic Capital Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$1.51M – 253
2014
Q3 		$1.51M Hold
50,000
– – 0.35% 101
2014
Q2 		$1.57M Buy
+50,000
New +$1.59M 0.5% 73

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Dialectic Capital Management's MR Position: Q2 2014 in Review

Dialectic Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 8,000 shares — an estimated $254K sold.

Dialectic Capital Management first reported a position in MR in Q1 2014 and held it in 1 quarter. The position peaked at $260K in Q1 2014. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • Dialectic Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • Dialectic Capital Management sold 8,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $254K.
  • Dialectic Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2014 and held it in 1 quarter.
  • Dialectic Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $260K in Q1 2014.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on Dialectic Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.